Skip to main content

Table 1 Recipients and donor characteristics for the year-1 MMP-9 comparative analysis

From: Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction

 

Stable (n = 104)

CLAD (n = 86)

p value

Missing value (%)

Gender male

61 (58.7)

45 (52.3)

0.5

0

Age

52 [36, 60]

51 [28, 58]

0.4

0

Height (cm)

168 (8)

165 (8)

0.05

0.5

Weight (kg)

61(15)

59 (13)

0.3

0.5

Underlying disease

0.01

0

 COPD/emphysema

55 (52.9)

33 (38.4)

  

 Cystic fibrosis

30 (28.8)

23 (26.7)

  

 ILD

16 (15.4)

17 (19.8)

  

 Other

3 (2.9)

13 (15.1)

  

Bacterial colo. pre Tx

51 (49.0)

43 (50.0)

1

0

Fungal colo. pre Tx

55 (52.9)

39 (45.3)

0.4

0

C. Albicans colo. pre Tx

37 (35.6)

18 (20.9)

0.04

0

DSA pre Tx

19 (24.7)

21 (32.8)

0.4

25.8

High emergency

8 (7.7)

6 (7.0)

1

0

Procedure

0.3

1.1

 Double lung

87 (84.5)

70 (82.4)

  

 Heart and lung

0 (0.0)

2 (2.4)

  

 Single lung

16 (15.5)

13 (15.3)

  

Surgical approach

0.2

4.7

 Clam shell

18 (18.2)

8 (9.8)

  

 Sternotomy

2 (2.0)

4 (4.9)

  

 Thoracotomy

79 (79.8)

70 (85.4)

  

ECLS

42 (42.0)

30 (35.7)

0.5

3.2

Graft cold ischemia (min)

322 [270, 380]

345 [280, 405]

0.12

3.7

Donor age

44 [30, 54]

46 [25, 57]

0.7

0.5

Donor gender male

62 (59.6)

53 (62.4)

0.8

0.5

Donor smoking habit

37 (35.9)

30 (36.6)

1

2.6

PaO2/FiO2

400 (106)

380 (107)

0.2

0.5

Mismatch CMV

16 (15.4)

16 (18.6)

0.7

0

Mismatch EBV

6 (5.8)

7 (8.1)

0.7

0

Dialysis

5 (5.1)

2 (2.4)

0.6

3.7

Induction treatment

87 (83.7)

60 (69.8)

0.03

0

Type of Induction

0.03

0

 Anti-IL2

36 (34.6)

20 (23.3)

  

 ATG

51 (49.0)

39 (45.3)

  

 None

17 (16.3)

27 (31.4)

  

Resp bacterial inf post Tx

0.3

0

 0

19 (18.3)

21 (24.4)

  

 1

40 (38.5)

24 (27.9)

  

 2

31 (29.8)

24 (27.9)

  

 3

14 (13.5)

17 (19.8)

  

Resp fungal inf post Tx

0.7

0

 0

55 (52.9)

43 (50.0)

  

 1

34 (32.7)

34 (39.5)

  

 2

12 (11.5)

7 (8.1)

  

 3

3 (2.9)

2 (2.3)

  

Resp viral inf post Tx

0.3

0

 0

66 (63.5)

50 (58.1)

  

 1

28 (26.9)

25 (29.1)

  

 2

6 (5.8)

10 (11.6)

  

 3

4 (3.8)

1 (1.2)

  

ACR (≥ 1)

31 (29.8)

37 (43.0)

0.08

0

AMR

3 (2.9)

7 (8.1)

0.2

0

  1. Results are expressed in median with interquartile range, mean with standard deviation or n and %. CLAD chronic lung allograft dysfunction, COPD: chronic obstructive pulmonary disease. ILD: interstitial lung disease. Other: other underlying diagnosis (pulmonary hypertension, sarcoidosis, connective tissue disease, bronchiectasis). Bacterial colo. pre Tx: bacterial colonization pre transplantation. Fungal colo. pre Tx. Fungal colonization pre transplantation. DSA: donor specific antibody. ECLS: extracorporeal life support per transplantation. CMV: cytomegalovirus. EBV: Epstein-Barr virus. ATG: rabbit antithymoglobulin. Anti-IL2: anti interleukine-2. Resp bacterial inf post Tx: lower respiratory tract bacterial infection in the first year post transplantation, number of episode. Resp fungal inf post Tx: lower respiratory tract fungal infection in the first year post transplantation, number of episode. ACR: acute cellular rejection, number of patients with one or more episode in the first year post transplantation. AMR: antibody mediated rejection, number of patients with one or more episode in the first year post transplantation